Glaxosmithkline Consumer Healthcare rises on getting shareholders’ nod for merger with HUL

03 Jun 2019 Evaluate

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7486.95, up by 75.15 points or 1.01% from its previous closing of Rs. 7411.80 on the BSE.

The scrip opened at Rs. 7494.45 and has touched a high and low of Rs. 7545.50 and Rs. 7460.00 respectively. So far 278 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 5985.00 on 25-Jun-2018.

Last one week high and low of the scrip stood at Rs. 7545.50 and Rs. 7250.00 respectively. The current market cap of the company is Rs. 31486.77 crore.

The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 11.49% and 16.05% respectively.

Glaxosmithkline Consumer Healthcare has received approval from its shareholders for merger with Hindustan Unilever (HUL). The company has received 99.99 percent votes in favour of the scheme of amalgamation among the company and HUL in the National Company Law Tribunal-convened meeting of the equity shareholders on June 1, 2019.

Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 2465.95
Britannia Inds 5087.15
Varun Beverages 1498.70
Marico 590.85
Hatsun Agro Product 1011.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.